UNSPSC 51284144: Cefteram pivoxil

This classification denotes a cephalosporin antibiotic C22H27N9O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0OD86RT58C, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-3-((5-methyl-2h-tetrazol-2-yl)methyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r,7r)-, but more generally known as cefteram pivoxil, which bears US NIH Compound Identifier 54885.

UNSPSC 51284144 Cefteram pivoxil is a Commodity code that nominally designates a specific cephalosporin antibiotic, yet recent state and local solicitations tagged under this code show little alignment with the code's pharmaceutical product scope. The tagged opportunities in the source instead cover broad medical and pharmaceutical procurement categories — naloxone and drug deactivation systems, first aid and emergency medical supplies, generic multi-source pharmaceuticals and OTC products, and direct-to-manufacturer prescription program infrastructure — none of which are cefteram pivoxil specifically. The issuing bodies span county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota MMCAP). This mix indicates the code is being applied as a catch-all tag for pharmaceutical and medical supply procurement rather than as a precise commodity classifier.

Geographic activity appears concentrated in Florida (Seminole County), Texas (HHS Commission), Minnesota and Oregon (MMCAP), and ongoing municipal activity in Tampa. Representative solicitations include Seminole County's IFB 60459723LAS (posted June 30, 2026, response due July 26, 2023) for 1,900 annual units of naloxone and 800 drug deactivation systems with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, response due March 13, 2026) for 169 line items of medical and first aid supplies estimated at $700,000.00 and designated as a sheltered Small Local Business Enterprise opportunity; and Minnesota MMCAP's RFP S1070000015802 (posted January 20, 2026, response due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities. The code shows minimal direct relevance to its stated scope — prospective vendors should verify whether actual cefteram pivoxil procurement exists under this designation or treat recent activity as a signal of code-taxonomy misalignment.